BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18838954)

  • 1. The treatment of giant cell arteritis.
    Fraser JA; Weyand CM; Newman NJ; Biousse V
    Rev Neurol Dis; 2008; 5(3):140-52. PubMed ID: 18838954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-ophthalmic complications in giant cell arteritis.
    Borg FA; Salter VL; Dasgupta B
    Curr Allergy Asthma Rep; 2008 Jul; 8(4):323-30. PubMed ID: 18606086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What have we learned about giant cell arteritis during the last decade?].
    Sailler L
    Rev Med Interne; 2004 Nov; 25(11):816-25. PubMed ID: 15501351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of recurrent ischemic optic neuropathy in giant cell arteritis.
    Chan CC; Paine M; O'day J
    J Neuroophthalmol; 2005 Mar; 25(1):14-7. PubMed ID: 15756126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuro-Ophthalmologic Complications of Giant Cell Arteritis: Diagnosis and Treatment.
    Fein AS; Ko MW
    Semin Neurol; 2019 Dec; 39(6):673-681. PubMed ID: 31847038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic ocular manifestations of giant cell arteritis: A Canadian case series.
    Issa M; Donaldson L; Jeeva-Patel T; Margolin E
    J Neurol Sci; 2022 May; 436():120222. PubMed ID: 35276478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
    Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
    Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant Cell Arteritis.
    Ness T; Nölle B
    Klin Monbl Augenheilkd; 2024 May; 241(5):644-652. PubMed ID: 38593832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.
    Kupersmith MJ; Langer R; Mitnick H; Spiera R; Spiera H; Richmond M; Paget S
    Br J Ophthalmol; 1999 Jul; 83(7):796-801. PubMed ID: 10381666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant cell arteritis: ophthalmic manifestations of a systemic disease.
    De Smit E; O'Sullivan E; Mackey DA; Hewitt AW
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2291-2306. PubMed ID: 27495301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual Recovery with Iloprost Added to Corticosteroids in a Case of Giant Cell Arteritis.
    Sené T; Arej N; Lecler A; Dupont C; Vasseur V; Mauget-Faÿsse M; Vignal-Clermont C
    Ocul Immunol Inflamm; 2022 Feb; 30(2):497-499. PubMed ID: 32976035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.
    Hayreh SS; Zimmerman B; Kardon RH
    Acta Ophthalmol Scand; 2002 Aug; 80(4):355-67. PubMed ID: 12190776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late ipsilateral recurrence of ischemic optic neuropathy in giant cell arteritis.
    Kim N; Trobe JD; Flint A; Keoleian G
    J Neuroophthalmol; 2003 Jun; 23(2):122-6. PubMed ID: 12782923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare Ischemic Complications of Giant Cell Arteritis: Case Series and Literature Review.
    Jalaledin DS; Ross C; Makhzoum JP
    Am J Case Rep; 2022 Oct; 23():e937565. PubMed ID: 36240129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
    Jover JA; Hernández-García C; Morado IC; Vargas E; Bañares A; Fernández-Gutiérrez B
    Ann Intern Med; 2001 Jan; 134(2):106-14. PubMed ID: 11177313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular complications of giant cell arteritis].
    Liozon E; Ly KH; Robert PY
    Rev Med Interne; 2013 Jul; 34(7):421-30. PubMed ID: 23523078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bilateral amaurosis in 11 patients with giant cell arteritis confirmed by arterial biopsy].
    Wenkel H
    Klin Monbl Augenheilkd; 2001 Oct; 218(10):658-61. PubMed ID: 11706381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell (temporal) arteritis.
    Caselli RJ; Hunder GG
    Neurol Clin; 1997 Nov; 15(4):893-902. PubMed ID: 9367971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab for giant cell arteritis with corticosteroid-resistant progressive anterior ischemic optic neuropathy.
    Vionnet J; Buss G; Mayer C; Sokolov AA; Borruat FX; Spertini F
    Joint Bone Spine; 2017 Oct; 84(5):615-619. PubMed ID: 28499892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.